Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-01-17 @ 3:30 AM
Study NCT ID:
NCT00529568
Status:
COMPLETED
Last Update Posted:
2013-11-05
First Post:
2007-09-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-12
First Submit QC Date:
None
Study First Post Date:
2007-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-04-19
Results First Submit QC Date:
None
Results First Post Date:
2012-05-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-10-10
Last Update Post Date:
2013-11-05
Last Update Post Date Type:
ESTIMATED